4
Changes in Ownership
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-25-010973
Options or other derivatives
- Chief Medical Officer acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ferguson James J. III · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-05 | Grant or award : show line 1 in the form Stock Options | +60,000 | 60,000 | D |
Loading xslF345X05/ownership.xml…